Financials
| Publication of Annual Report | Apr. 29, 2024 |
| Half-year Report | Aug. 17, 2023 |
| Final Results | Apr. 26, 2023 |
| Half-year Report | Aug. 16, 2022 |
| Imaging Biometrics Announces Channel Partnership | Jul. 11, 2022 |
| Final Results | Apr. 28, 2022 |
| Half Yearly Report | Aug. 27, 2021 |
Proxies
| Result of AGM | May. 29, 2024 |
| Result of AGM | May. 23, 2023 |
| AGM Statement | May. 23, 2023 |
| Result of AGM | May. 30, 2022 |
| Notice of AGM | May. 05, 2022 |
| Result of AGM | May. 19, 2021 |
| Notice of AGM | Apr. 27, 2021 |
Ownership Update
| Grant of Options | Mar. 05, 2024 |
| Holding(s) in Company | Mar. 01, 2024 |
| Holding(s) in Company | Mar. 01, 2024 |
| Holding(s) in Company | Jan. 22, 2024 |
| Holding(s) in Company | Nov. 20, 2023 |
| Director Dealing and Conversion of CLNs | Nov. 09, 2023 |
| Holding(s) in Company | Nov. 06, 2023 |
Announcements
| IB Opens Expanded Access Program | Jun. 25, 2024 |
| Clinical Trial Updates | Jun. 14, 2024 |
| Major East Coast Health System Chooses IB Nimble | May. 23, 2024 |
| Second FDA Rare Pediatric Disease Designation | May. 20, 2024 |
| IB Software Enhances Clinical Decision-Making | May. 17, 2024 |
| Rare Pediatric Disease Designation Granted to GaM | May. 10, 2024 |
| IB Announces Expanded Access Program for GaM | May. 02, 2024 |